NR3C1 and neoplasm: Inhibition of XPO1 thus impacts tumour cells via 3 core mechanisms: increasing nuclear levels and activation of TSPs; trapping oncoprotein mRNA in the nucleus, leading to reduced oncoprotein levels; and retaining activated glucocorticoid receptor (GR) in the nucleus (Figure 1) [24, 29].